Literature DB >> 24974977

Matrix metalloproteinases are involved in cardiovascular diseases.

Aline Azevedo1, Alejandro F Prado, Raquel C Antonio, Joao P Issa, Raquel F Gerlach.   

Abstract

This MiniReview describes the essential biochemical and molecular aspects of matrix metalloproteinases (MMPs) and briefly discusses how they engage in different diseases, with particular emphasis on cardiovascular diseases. There is compelling scientific evidence that many MMPs, especially MMP-2, play important roles in the development of cardiovascular diseases; inhibition of these enzymes is beneficial to many cardiovascular conditions, sometimes precluding or postponing end-organ damage and fatal outcomes. Conducting comprehensive discussions and further studies on how MMPs participate in cardiovascular diseases is important, because inhibition of these enzymes may be an alternative or an adjuvant for current cardiovascular disease therapy.
© 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24974977     DOI: 10.1111/bcpt.12282

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  20 in total

1.  Nanoparticle-mediated arresten gene inhibits neointimal formation of vein grafts: an experimental research.

Authors:  Rong-Fei Wang; Qing-Yi Meng
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Treponema denticola increases MMP-2 expression and activation in the periodontium via reversible DNA and histone modifications.

Authors:  Islam M Ateia; Pimchanok Sutthiboonyapan; Pachiyappan Kamarajan; Taocong Jin; Valentina Godovikova; Yvonne L Kapila; J Christopher Fenno
Journal:  Cell Microbiol       Date:  2018-01-08       Impact factor: 3.715

3.  Matrix Metalloproteinase-Deactivating Contact Lens for Corneal Melting.

Authors:  Chelsi Lopez; Shiwha Park; Seth Edwards; Selina Vong; Shujie Hou; Minyoung Lee; Hunter Sauerland; Jung-Jae Lee; Kyung Jae Jeong
Journal:  ACS Biomater Sci Eng       Date:  2019-01-04

4.  Identifying simultaneous matrix metalloproteinases/soluble epoxide hydrolase inhibitors.

Authors:  Ahmed A El-Sherbeni; Rabia Bhatti; Fadumo A Isse; Ayman O S El-Kadi
Journal:  Mol Cell Biochem       Date:  2022-01-24       Impact factor: 3.396

5.  Cathepsin K knockout protects against cardiac dysfunction in diabetic mice.

Authors:  Rui Guo; Yinan Hua; Olivia Rogers; Travis E Brown; Jun Ren; Sreejayan Nair
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

6.  Local honokiol application inhibits intimal thickening in rabbits following carotid artery balloon injury.

Authors:  Yu Wang; Danyang Zhao; Jing Sheng; Ping Lu
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

Review 7.  Message in a Microbottle: Modulation of Vascular Inflammation and Atherosclerosis by Extracellular Vesicles.

Authors:  Emiel P C van der Vorst; Renske J de Jong; Marjo M P C Donners
Journal:  Front Cardiovasc Med       Date:  2018-01-22

8.  Mdivi-1 induced acute changes in the angiogenic profile after ischemia-reperfusion injury in female mice.

Authors:  Sudhakar Veeranki; Suresh C Tyagi
Journal:  Physiol Rep       Date:  2017-06

9.  The Involvement of miR-29b-3p in Arterial Calcification by Targeting Matrix Metalloproteinase-2.

Authors:  Wenhong Jiang; Zhanman Zhang; Han Yang; Qiuning Lin; Chuangye Han; Xiao Qin
Journal:  Biomed Res Int       Date:  2017-01-09       Impact factor: 3.411

10.  Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction.

Authors:  Alejandro F Prado; Laena Pernomian; Aline Azevedo; Rute A P Costa; Elen Rizzi; Junia Ramos; Adriana F Paes Leme; Lusiane M Bendhack; Jose E Tanus-Santos; Raquel F Gerlach
Journal:  Redox Biol       Date:  2018-07-09       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.